Published in Women's Health Weekly, May 26th, 2005
"The finding that COX-1 inhibition slowed the growth of epithelial ovarian tumors in a mouse model of the disease is surprising," said Sudhansu K. Dey, PhD, senior author of the paper and director of the Division of Reproductive and Developmental Biology in the Vanderbilt Department of Pediatrics.
Previous studies have linked high levels of another cyclooxygenase enzyme, COX-2, to colorectal and other cancers.
"But this is the exception," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly